Integrated Filing — IndAS



General information about company
Scrip Code 530549
NSE Symbol SHILPAMED
MSEI Symbol NOTLISTED
ISIN INE790G01031
Name of company SHILPA MEDICARE LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 26-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 19-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment PHARMACETICAL
Start date and time of board meeting 26-May-2025   12:47:00
End date and time of board meeting 26-May-2025   16:15:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-02-10
Indicate Company website link for updated RPT policy of the Company https://vbshilpa.com/policies-and-codes.php
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NOT APPLICABLE



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 1261536000 4773421000
Other income 140841000 838335000
Total income 1402377000 5611756000
2 Expenses
(a) Cost of materials consumed 345430000 998252000
(b) Purchases of stock-in-trade 54506000 146777000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 60078000 60049000
(d) Employee benefit expense 226903000 996058000
(e) Finance costs 20881000 66037000
(f) Depreciation, depletion and amortisation expense 123384000 488555000
(f) Other Expenses
1 Other Expenses 222286000 1326269000
Total other expenses 222286000 1326269000
Total expenses 1053468000 4081997000
3 Total profit before exceptional items and tax 348909000 1529759000
4 Exceptional items -443204000 -457381000
5 Total profit before tax -94295000 1072378000
6 Tax expense
7 Current tax 16636000 470776000
8 Deferred tax -59393000 -96427000
9 Total tax expenses -42757000 374349000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations -51538000 698029000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period -51538000 698029000
17 Other comprehensive income net of taxes -19431000 -19431000
18 Total Comprehensive Income for the period -70969000 678598000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 97791000 97791000
Face value of equity share capital 1 0
27 Details of debt securities
22 Reserves excluding revaluation reserve 26908131000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -0.53 7.16
Diluted earnings (loss) per share from continuing operations -0.53 7.16
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -0.53 7.16
Diluted earnings (loss) per share from continuing and discontinued operations -0.53 7.16
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 4406051000
Capital work-in-progress 394608000
Investment property 0
Goodwill 0
Other intangible assets 1294707000
Intangible assets under development 2415539000
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 12795006000
Trade receivables, non-current
Loans, non-current 3887023000
Other non-current financial assets 27552000
Total non-current financial assets 16709581000
Deferred tax assets (net)
Other non-current assets 73281000
Total non-current assets 25293767000
2 Current assets
Inventories 1485799000
Current financial asset
Current investments 0
Trade receivables, current 1905196000
Cash and cash equivalents 32902000
Bank balance other than cash and cash equivalents 11308000
Loans, current 0
Other current financial assets 801566000
Total current financial assets 2750972000
Current tax assets (net) 76764000
Other current assets 459319000
Total current assets 4772854000
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 30066621000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 97791000
Other equity 26908131000
Total equity attributable to owners of parent 27005922000
Non controlling interest
Total equity 27005922000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 244694000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
Total non-current financial liabilities 244694000
Provisions, non-current 39754000
Deferred tax liabilities (net) 424286000
Deferred government grants, Non-current
Other non-current liabilities 83107000
Total non-current liabilities 791841000
Current liabilities
Current financial liabilities
Borrowings, current 824315000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 13485000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 208433000
Total Trade payable 221918000
Other current financial liabilities 504868000
Total current financial liabilities 1551101000
Other current liabilities 165718000
Provisions, current 552039000
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 2268858000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 3060699000
Total equity and liabilites 30066621000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of the defined benefit (liability)/asset -29866000 -29866000
Total Amount of items that will not be reclassified to profit and loss -29866000 -29866000
2 Income tax relating to items that will not be reclassified to profit or loss -10435000 -10435000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income -19431000 -19431000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 1072378000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 65764000
Adjustments for decrease (increase) in inventories -472889000
Adjustments for decrease (increase) in trade receivables, current -474644000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 0
Adjustments for decrease (increase) in other non-current assets -537129000
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current -291748000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 614646000
Adjustments for depreciation and amortisation expense 488555000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss -10163000
Adjustments for provisions, current 0
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains -51929000
Adjustments for dividend income 28631000
Adjustments for interest income 605218000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 205805000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -1097581000
Net cash flows from (used in) operations -25203000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 173690000
Other inflows (outflows) of cash 8294000
Net cash flows from (used in) operating activities -190599000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 3595556000
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 145821000
Purchase of property, plant and equipment 574428000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 881611000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -1190315000
Net cash flows from (used in) investing activities -4332867000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 4896063000
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings -331877000
Repayments of borrowings 0
Payments of lease liabilities 0
Dividends paid 0
Interest paid 60805000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -2521000
Net cash flows from (used in) financing activities 4500860000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -22606000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -22606000
Cash and cash equivalents cash flow statement at beginning of period 0
Cash and cash equivalents cash flow statement at end of period -22606000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 BNPS AND ASSOCIATES LLP Yes 31-May-2028


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Shilpa Medicare Limited Vishnukant.C. Bhutada Managing Director Remuneration Approved 17500000 -1583000 -1207000
2 Shilpa Medicare Limited Omprakash Inani Non-executive Director Any other transaction Sitting Fees Approved 200000 -200000 -90000
3 Shilpa Medicare Limited Deepak Innani Promoter Group/ General Manager Remuneration Approved 5667000 -494000 -514000
4 Shilpa Medicare Limited Ramakant Innani Promoter Group/ General Manager Remuneration Approved 5960000 -525000 -516000
5 Shilpa Medicare Limited Ravi Kumar Innani Promoter Group/ General Manager Remuneration Approved 4300000 -333000 -343000
6 Shilpa Medicare Limited Sagar Inani Promoter Group/ Executive Remuneration Approved 906000 -84000 -92000
7 Shilpa Medicare Limited Koanna Healthcare GmbH, Austria Wholly owned Subsidiary Any other transaction Interest Income (Loan) Approved 17036000 0 0
8 Shilpa Medicare Limited Koanna Healthcare GmbH, Austria Wholly owned Subsidiary Loan Approved 0 477443000 471269000
9 Shilpa Medicare Limited Koanna Healthcare GmbH, Austria Wholly owned Subsidiary Any other transaction Trade Receivable Approved 0 299000 295000
10 Shilpa Medicare Limited Koanna Healthcare GmbH, Austria Wholly owned Subsidiary Any other transaction Trade Payable Approved 0 0 -109521000
11 Shilpa Medicare Limited Koanna Healthcare GmbH, Austria Wholly owned Subsidiary Any other transaction Interest accrued but not received (Loan) Approved 0 41818000 58665000
12 Shilpa Medicare Limited Koanna Healthcare GmbH, Austria Wholly owned Subsidiary Investment Approved 0 7763000 7763000
13 Shilpa Medicare Limited Koanna Healthcare GmbH, Austria Wholly owned Subsidiary Purchase of goods or services Approved 109521000 0 0
14 Shilpa Medicare Limited Koanna Healthcare Ltd, United Kingdom Wholly owned Subsidiary Any other transaction Interest Income (Loan) Approved 3406000 0 0
15 Shilpa Medicare Limited Koanna Healthcare Ltd, United Kingdom Wholly owned Subsidiary Loan Approved 0 96651000 95427000
16 Shilpa Medicare Limited Koanna Healthcare Ltd, United Kingdom Wholly owned Subsidiary Any other transaction Interest accrued but not received (Loan) Approved 0 12148000 15513000
17 Shilpa Medicare Limited Koanna Healthcare Ltd, United Kingdom Wholly owned Subsidiary Any other transaction Investment in equity Shares Approved 0 10000 10000
18 Shilpa Medicare Limited Koanna Healthcare Ltd, United Kingdom Wholly owned Subsidiary Any other transaction Purchases of Capital goods Approved 56560000 0 0
19 Shilpa Medicare Limited Koanna Healthcare Ltd, United Kingdom Wholly owned Subsidiary Any other transaction Trade payable Approved 0 0 -56560000
20 Shilpa Medicare Limited Shilpa Therapeutics Pvt. Ltd. Wholly owned Subsidiary Purchase of goods or services Approved -328000 0 0
21 Shilpa Medicare Limited Shilpa Therapeutics Pvt. Ltd. Wholly owned Subsidiary Any other transaction Purchases of Capital goods Approved 6382000 0 0
22 Shilpa Medicare Limited Shilpa Therapeutics Pvt. Ltd. Wholly owned Subsidiary Any other transaction Sales of Goods or Service Approved 89000 0 0
23 Shilpa Medicare Limited Shilpa Therapeutics Pvt. Ltd. Wholly owned Subsidiary Any other transaction Other Income Approved 113000 0 0
24 Shilpa Medicare Limited Shilpa Therapeutics Pvt. Ltd. Wholly owned Subsidiary Any other transaction Interest Income (Loan) Approved 31930000 0 0
25 Shilpa Medicare Limited Shilpa Therapeutics Pvt. Ltd. Wholly owned Subsidiary Any other transaction Dividend Income (Preference shares) Approved 160000 0 0
26 Shilpa Medicare Limited Shilpa Therapeutics Pvt. Ltd. Wholly owned Subsidiary Any other transaction Loan repaid during the year Approved 8056000 0 0
27 Shilpa Medicare Limited Shilpa Therapeutics Pvt. Ltd. Wholly owned Subsidiary Any other transaction Loan Receivable Approved 0 853806000 845750000
28 Shilpa Medicare Limited Shilpa Therapeutics Pvt. Ltd. Wholly owned Subsidiary Any other transaction Trade Payable Approved 0 -290000 0
29 Shilpa Medicare Limited Shilpa Therapeutics Pvt. Ltd. Wholly owned Subsidiary Any other transaction Interest accrued but not received (Loan) Approved 0 30161000 55882000
30 Shilpa Medicare Limited Shilpa Therapeutics Pvt. Ltd. Wholly owned Subsidiary Any other transaction Dividend accrued but not received (Pref Share) Approved 0 3361000 3521000
31 Shilpa Medicare Limited Shilpa Therapeutics Pvt. Ltd. Wholly owned Subsidiary Any other transaction Investment in equity Shares Approved 0 111246000 111246000
32 Shilpa Medicare Limited Shilpa Therapeutics Pvt. Ltd. Wholly owned Subsidiary Any other transaction Investment in Preference equity Shares Approved 0 4000000 4000000
33 Shilpa Medicare Limited INM Technologies Private Limited Wholly owned Subsidiary Interest paid Approved 3664000 0 0
34 Shilpa Medicare Limited INM Technologies Private Limited Wholly owned Subsidiary Dividend received Approved 12979000 0 0
35 Shilpa Medicare Limited INM Technologies Private Limited Wholly owned Subsidiary Loan Approved 6500000 0 0
36 Shilpa Medicare Limited INM Technologies Private Limited Wholly owned Subsidiary Any other transaction Loan Payable Approved 0 -97333000 -103933000
37 Shilpa Medicare Limited INM Technologies Private Limited Wholly owned Subsidiary Any other transaction Interest due but not paid (Loan) Approved 0 -9749000 -6595000
38 Shilpa Medicare Limited INM Technologies Private Limited Wholly owned Subsidiary Any other transaction Dividend accrued but not received (Pref Share) Approved 0 209583000 222562000
39 Shilpa Medicare Limited INM Technologies Private Limited Wholly owned Subsidiary Any other transaction IInvestment in equity Shares Approved 0 11325000 11325000
40 Shilpa Medicare Limited INM Technologies Private Limited Wholly owned Subsidiary Any other transaction Investment in Preference Shares Approved 0 424677000 424677000
41 Shilpa Medicare Limited Reva Medicare Pvt. Ltd. Joint Venture Any other transaction Commission Charges Approved 1567000 0 0
42 Shilpa Medicare Limited Reva Medicare Pvt. Ltd. Joint Venture Any other transaction Other Income Approved 210000 0 0
43 Shilpa Medicare Limited Reva Medicare Pvt. Ltd. Joint Venture Any other transaction Trade Payable Approved 0 -650000 -4878000
44 Shilpa Medicare Limited Reva Medicare Pvt. Ltd. Joint Venture Any other transaction Commission Accrued but not paid Approved 0 -7780000 -5819000
45 Shilpa Medicare Limited Reva Medicare Pvt. Ltd. Joint Venture Any other transaction Trade Receivable Approved 0 41000 165000
46 Shilpa Medicare Limited Reva Medicare Pvt. Ltd. Joint Venture Any other transaction Investment in equity shares Approved 0 50000 50000
47 shilpa Medicare Limited Maia Pharmaceuticals INC. USA Associates Any other transaction Investment in Preference Shares Approved 0 79569000 79569000
48 Shilpa Medicare Limited Shilpa Pharma INC. USA Wholly owned Subsidiary Interest received Approved 2445000 0 0
49 Shilpa Medicare Limited Shilpa Pharma INC. USA Wholly owned Subsidiary Any other transaction Interest accrued but not received (Loan) Approved 0 7447000 10084000
50 Shilpa Medicare Limited Shilpa Pharma INC. USA Wholly owned Subsidiary Loan Approved 38734000 0 0
51 Shilpa Medicare Limited Shilpa Pharma INC. USA Wholly owned Subsidiary Any other transaction Loan Receivable Approved 0 47341000 86865000
52 Shilpa Medicare Limited Shilpa Pharma INC. USA Wholly owned Subsidiary Any other transaction investment in equity shares Approved 0 7000 7000
53 Shilpa Medicare Limited Sravathi Advance Process Technologies Pvt. Ltd. Joint Venture Any other transaction Investment in equity shares Approved 0 399558000 399558000
54 Shilpa Medicare Limited Shilpa Biocare Private Limited Wholly owned Subsidiary Sale of goods or services Approved 7390000 0 0
55 Shilpa Medicare Limited Shilpa Biocare Private Limited Wholly owned Subsidiary Interest received Approved 31867000 0 0
56 Shilpa Medicare Limited Shilpa Biocare Private Limited Wholly owned Subsidiary Loan Approved 750971000 0 0
57 Shilpa Medicare Limited Shilpa Biocare Private Limited Wholly owned Subsidiary Any other transaction Loan Received Approved 7000 0 0
58 Shilpa Medicare Limited Shilpa Biocare Private Limited Wholly owned Subsidiary Any other transaction loan Receivable Approved 0 2676037000 367300000
59 Shilpa Medicare Limited Shilpa Biocare Private Limited Wholly owned Subsidiary Any other transaction Interest accrued but not received (Loan) Approved 0 93813000 1942000
60 Shilpa Medicare Limited Shilpa Biocare Private Limited Wholly owned Subsidiary Any other transaction trade receivable Approved 0 14606000 18000
61 Shilpa Medicare Limited Shilpa Biocare Private Limited Wholly owned Subsidiary Any other transaction CG TO BANKS Approved 1404200000 1500000000 1404200000
62 Shilpa Medicare Limited Shilpa Biocare Private Limited Wholly owned Subsidiary Any other transaction CG TO BANKS CLOSED Approved 1500000000 0 0
63 Shilpa Medicare Limited Shilpa Biocare Private Limited Wholly owned Subsidiary Any other transaction CG INCOME Approved 5040000 0 0
64 Shilpa Medicare Limited Shilpa Biocare Private Limited Wholly owned Subsidiary Any other transaction Investment in equity shares Approved 436800000 200000000 3696500000
65 Shilpa Medicare Limited Shilpa Biocare Private Limited Wholly owned Subsidiary Any other transaction Advance to Vendors Approved 0 10164000 51000
66 Shilpa Medicare Limited Shilpa Biocare Private Limited Wholly owned Subsidiary Any other transaction Loan converted into equity approved 3059700000 0 0
67 Shilpa Medicare Limited Shilpa Biologicals Private Limited Wholly owned Subsidiary Sale of goods or services Approved 67000 0 0
68 Shilpa Medicare Limited Shilpa Biologicals Private Limited Wholly owned Subsidiary Sale of goods or services Approved 857000 0 0
69 Shilpa Medicare Limited Shilpa Biologicals Private Limited Wholly owned Subsidiary Any other transaction Other Income Approved 109000 0 0
70 Shilpa Medicare Limited Shilpa Biologicals Private Limited Wholly owned Subsidiary Purchase of goods or services Approved 8738000 0 0
71 Shilpa Medicare Limited Shilpa Biologicals Private Limited Wholly owned Subsidiary Purchase of goods or services Approved 6030000 0 0
72 Shilpa Medicare Limited Shilpa Biologicals Private Limited Wholly owned Subsidiary Interest received Approved 17851000 0 0
73 Shilpa Medicare Limited Shilpa Biologicals Private Limited Wholly owned Subsidiary Any other transaction Trade Receivable Approved 0 5993000 4830000
74 Shilpa Medicare Limited Shilpa Biologicals Private Limited Wholly owned Subsidiary Any other transaction Trade Payable Approved 0 -7039000 -3856000
75 Shilpa Medicare Limited Shilpa Biologicals Private Limited Wholly owned Subsidiary Any other transaction Loan given during the year(incl Interest accrued till last year) Approved 205150000 0 0
76 Shilpa Medicare Limited Shilpa Biologicals Private Limited Wholly owned Subsidiary Any other transaction Loan given received back Approved 82500000 0 0
77 Shilpa Medicare Limited Shilpa Biologicals Private Limited Wholly owned Subsidiary Any other transaction Loan Recievable Approved 0 374399000 497049000
78 Shilpa Medicare Limited Shilpa Biologicals Private Limited Wholly owned Subsidiary Any other transaction Interest accrued but not received (Loan) Approved 0 4642000 20243000
79 Shilpa Medicare Limited Shilpa Biologicals Private Limited Wholly owned Subsidiary Any other transaction investment in equity shares Approved 750000000 7170095000 7170095000
80 Shilpa Medicare Limited Shilpa Biologicals Private Limited Wholly owned Subsidiary Any other transaction advance to Vendors Approved 0 0 44000
81 Shilpa Medicare Limited Shilpa Foundation Trust in which key management are the board of trustees Any other transaction Corporate Social Responsibility Expenses Approved 6349000 0 0
82 Shilpa Medicare Limited FTF PHARMA PVT LTD Wholly owned Subsidiary Sale of goods or services Approved 79000 0 0
83 Shilpa Medicare Limited FTF PHARMA PVT LTD Wholly owned Subsidiary Sale of goods or services Approved 69067000 0 0
84 Shilpa Medicare Limited FTF PHARMA PVT LTD Wholly owned Subsidiary Sale of goods or services Approved 226000 0 0
85 Shilpa Medicare Limited FTF PHARMA PVT LTD Wholly owned Subsidiary Any other transaction Other Income Approved 186000 0 0
86 Shilpa Medicare Limited FTF PHARMA PVT LTD Wholly owned Subsidiary Purchase of goods or services Approved 1360000 0 0
87 Shilpa Medicare Limited FTF PHARMA PVT LTD Wholly owned Subsidiary Purchase of goods or services Approved 25610000 0 0
88 Shilpa Medicare Limited FTF PHARMA PVT LTD Wholly owned Subsidiary Any other transaction Advance to Vendors Approved 0 5212000 38000
89 Shilpa Medicare Limited FTF PHARMA PVT LTD Wholly owned Subsidiary Any other transaction Trade Receivable Approved 0 43353000 125419000
90 Shilpa Medicare Limited FTF PHARMA PVT LTD Wholly owned Subsidiary Any other transaction investment in equity shares Approved 0 657797000 657797000
91 Shilpa Medicare Limited FTF PHARMA PVT LTD Wholly owned Subsidiary Any other transaction Investment in Preference Shares Approved 0 39000000 39000000
92 Shilpa Medicare Limited FTF PHARMA PVT LTD Wholly owned Subsidiary Any other transaction Dividend on Pref shares Approved 1141000 0 0
93 Shilpa Medicare Limited FTF PHARMA PVT LTD Wholly owned Subsidiary Any other transaction Dividend accrued but not received (Preference shares) Approved 0 3234000 4374000
94 Shilpa Medicare Limited FTF PHARMA PVT LTD Wholly owned Subsidiary Any other transaction Trade payable Approved 0 -8333000 -6229000
95 Shilpa Medicare Limited Koanna Healthcare Canada INC Wholly owned Subsidiary Any other transaction Interest Income (Loan) Approved 4343000 0 0
96 Shilpa Medicare Limited Koanna Healthcare Canada INC Wholly owned Subsidiary Loan Approved 4665000 0 0
97 Shilpa Medicare Limited Koanna Healthcare Canada INC Wholly owned Subsidiary Any other transaction Conversion of Loan into Inv in Equity (incl interest accrued) Approved 144932000 0 0
98 Shilpa Medicare Limited Koanna Healthcare Canada INC Wholly owned Subsidiary Any other transaction Loan Recievable Approved 0 136364000 0
99 Shilpa Medicare Limited Koanna Healthcare Canada INC Wholly owned Subsidiary Any other transaction Interest accrued but not received (Loan) Approved 0 4861000 1745000
100 Shilpa Medicare Limited Koanna Healthcare Canada INC Wholly owned Subsidiary Any other transaction investment in equity shares Approved 0 6000 158615000
101 Shilpa Medicare Limited Shilpa Pharma Lifesciences Limited Wholly owned Subsidiary Any other transaction Reimbursement of Expense (cross charges) Approved 64166000 0 0
102 Shilpa Medicare Limited Shilpa Pharma Lifesciences Limited Wholly owned Subsidiary Sale of goods or services Approved 1346000 0 0
103 Shilpa Medicare Limited Shilpa Pharma Lifesciences Limited Wholly owned Subsidiary Any other transaction Wind Energy Sales Approved 9864000 0 0
104 Shilpa Medicare Limited Shilpa Pharma Lifesciences Limited Wholly owned Subsidiary Any other transaction Sales of Capital Goods Approved 18944000 0 0
105 Shilpa Medicare Limited Shilpa Pharma Lifesciences Limited Wholly owned Subsidiary Purchase of goods or services Approved 897683000 0 0
106 Shilpa Medicare Limited Shilpa Pharma Lifesciences Limited Wholly owned Subsidiary Interest received Approved 74231000 0 0
107 Shilpa Medicare Limited Shilpa Pharma Lifesciences Limited Wholly owned Subsidiary Any other transaction Interest accrued but not received (Loan) Approved 0 38826000 101751000
108 Shilpa Medicare Limited Shilpa Pharma Lifesciences Limited Wholly owned Subsidiary Any other transaction Trade Payable(including transit Pur) Approved 0 -257334000 -180382000
109 Shilpa Medicare Limited Shilpa Pharma Lifesciences Limited Wholly owned Subsidiary Any other transaction Loan given received back Approved 915000000 0 0
110 Shilpa Medicare Limited Shilpa Pharma Lifesciences Limited Wholly owned Subsidiary Any other transaction Loan Recievable Approved 0 2302650000 1387650000
111 Shilpa Medicare Limited Shilpa Pharma Lifesciences Limited Wholly owned Subsidiary Any other transaction Trade Receivable Approved 0 90331000 12716000
112 Shilpa Medicare Limited Shilpa Pharma Lifesciences Limited Wholly owned Subsidiary Any other transaction Investment in Equity shares Approved 0 100000000 100000000
113 Shilpa Medicare Limited Shilpa Pharma Lifesciences Limited Wholly owned Subsidiary Any other transaction Corporate Guarantees to Banks/NCD Approved 0 1500000000 750000000
114 Shilpa Medicare Limited Shilpa Pharma Lifesciences Limited Wholly owned Subsidiary Any other transaction Corporate Guarentee Income Approved 7790000 0 0
115 Shilpa Medicare Limited Shilpa Pharma Lifesciences Limited Wholly owned Subsidiary Any other transaction Advance to Vendors Approved -58970000 58970000 0
116 Shilpa Medicare Limited INDO BIOTECH SDN. BHD Wholly owned Subsidiary Any other transaction Interst income Loan Approved 2502000 0 0
117 Shilpa Medicare Limited INDO BIOTECH SDN. BHD Wholly owned Subsidiary Any other transaction Interest accrued but not received (Loan) Approved 0 3256000 5765000
118 Shilpa Medicare Limited INDO BIOTECH SDN. BHD Wholly owned Subsidiary Any other transaction Loan Recievable Approved 0 94681000 13870000
119 Shilpa Medicare Limited INDO BIOTECH SDN. BHD Wholly owned Subsidiary Any other transaction Investment in equity shares Approved 0 442000 442000
120 Shilpa Medicare Limited INDO BIOTECH SDN. BHD Wholly owned Subsidiary Any other transaction Loan repaid during the year Approved 83523000 0 0
121 Shilpa Medicare Limited Koanna International FZ LLC. UAE Wholly owned Subsidiary Any other transaction Interst income Loan Approved 2275000 0 0
122 Shilpa Medicare Limited Koanna International FZ LLC. UAE Wholly owned Subsidiary Any other transaction Interest accrued but not received (Loan) Approved 0 2369000 4686000
123 Shilpa Medicare Limited Koanna International FZ LLC. UAE Wholly owned Subsidiary Loan Approved 0 61166000 62447000
124 Shilpa Medicare Limited Koanna International FZ LLC. UAE Wholly owned Subsidiary Any other transaction investment in equity shares Approved 0 198000 198000
125 Shilpa Medicare Limited Koanna International FZ LLC. UAE Wholly owned Subsidiary Any other transaction Advance to Vendors Approved 0 968000 909000
126 Shilpa Medicare Limited Koanaa Healthcare Spain, S.L. Spain Wholly owned Subsidiary Sale of goods or services Approved 12540000 0 0
127 Shilpa Medicare Limited Koanaa Healthcare Spain, S.L. Spain Wholly owned Subsidiary Interest received Approved 4091000 0 0
128 Shilpa Medicare Limited Koanaa Healthcare Spain, S.L. Spain Wholly owned Subsidiary Any other transaction Professional Fee paid Approved 14580000 0 0
129 Shilpa Medicare Limited Koanaa Healthcare Spain, S.L. Spain Wholly owned Subsidiary Any other transaction Interest accrued but not received (Loan) Approved 0 3600000 7728000
130 Shilpa Medicare Limited Koanaa Healthcare Spain, S.L. Spain Wholly owned Subsidiary Purchase of fixed assets Approved 53127000 0 0
131 Shilpa Medicare Limited Koanaa Healthcare Spain, S.L. Spain Wholly owned Subsidiary Any other transaction Loan Recievable Approved 0 104290000 116791000
132 Shilpa Medicare Limited Koanaa Healthcare Spain, S.L. Spain Wholly owned Subsidiary Any other transaction Investment in Equity shares Approved 0 624000 624000
133 Shilpa Medicare Limited Koanaa Healthcare Spain, S.L. Spain Wholly owned Subsidiary Any other transaction CG Approved 0 14965000 0
134 Shilpa Medicare Limited Koanaa Healthcare Spain, S.L. Spain Wholly owned Subsidiary Any other transaction trade receivable Approved 0 7857000 12925000
135 Shilpa Medicare Limited Koanaa Healthcare Spain, S.L. Spain Wholly owned Subsidiary Any other transaction Trade payable Approved 0 0 -42123000
136 Shilpa Medicare Limited Koanaa Healthcare Spain, S.L. Spain Wholly owned Subsidiary Any other transaction Laon Given during the period Approved 13526000 0 0
137 Shilpa Medicare Limited Vegil labs Private Limited wholly owned Subsidiary Any other transaction Investment in Equity shares Approved 0 95100000 95100000
138 Shilpa Medicare Limited Vegil labs Private Limited wholly owned Subsidiary Any other transaction Loan Received Approved 80702000 0 0
139 Shilpa Medicare Limited Vegil labs Private Limited wholly owned Subsidiary Any other transaction Loan Paid Approved 5000000 0 0
140 Shilpa Medicare Limited Vegil labs Private Limited wholly owned Subsidiary Any other transaction Loan Payable Approved 0 -65761000 -140761000
141 Shilpa Medicare Limited Vegil labs Private Limited wholly owned Subsidiary Any other transaction Interest PAID' Approved 2911000 0 0
142 Shilpa Medicare Limited Vegil labs Private Limited wholly owned Subsidiary Any other transaction Interest due but not paid (Loan) Approved 0 -2473000 -4845000
143 Shilpa Medicare Limited Shilpa Lifesciences Private Limited Step down Subsidiary Interest received Approved 1078000 0 0
144 Shilpa Medicare Limited Shilpa Lifesciences Private Limited Step down Subsidiary Any other transaction Interest accrued but not received (Loan) Approved 0 1048000 1946000
145 Shilpa Medicare Limited Shilpa Lifesciences Private Limited Step down Subsidiary Any other transaction Loan Recievable Approved 0 28836000 28836000
146 Shilpa Medicare Limited Makindus LLC USA Wholly owned Subsidiary Any other transaction Investment in Equity shares Approved 0 45420000 45420000
147 Shilpa Medicare Limited Pilnova Pharma INC USA Wholly owned Subsidiary Any other transaction Investment in Equity shares Approved 0 8000 8000
148 Shilpa Medicare Limited Pilnova Pharma INC USA Wholly owned Subsidiary Any other transaction Loan During the period Approved 42620000 0 0
149 Shilpa Medicare Limited Pilnova Pharma INC USA Wholly owned Subsidiary Any other transaction Loan Reecievable Approved 0 79599000 124039000
150 Shilpa Medicare Limited Pilnova Pharma INC USA Wholly owned Subsidiary Any other transaction Interest RECEIVED Approved 3991000 0 0
151 Shilpa Medicare Limited Pilnova Pharma INC USA Wholly owned Subsidiary Any other transaction Interest accrued but not received (Loan) Approved 0 1951000 6047000
152 Shilpa Medicare Limited Pilnova Pharma INC USA Wholly owned Subsidiary Sale of goods or services Approved 23158000 0 0
153 Shilpa Medicare Limited Pilnova Pharma INC USA Wholly owned Subsidiary Any other transaction trade receivable Approved 0 15654000 39552000
Total value of transaction during the reporting period 11134470000